Overview
- 8 inspections across 8 sites are on record.
- 17 Form 483 observations are attributed to this investigator.
- Most recent recorded activity is 2022-12-01.
At a glance
Inspections
8
Sites
8
Observations
17
Career since
Mar 2020
Recent inspections
Most recent inspections in the published record.
| Site | Date | Category | Form 483 |
|---|---|---|---|
| Silgan Unicep Packaging, LLC. | 1 Dec 2022 | Human Drugs | |
| Lonza Bend Inc. | 5 Aug 2022 | Human Drugs | View 483 → |
| Lonza Bend Inc. | 5 Aug 2022 | Human Drugs | View 483 → |
| Omya Inc. | 27 May 2022 | Human Drugs | On file |
| Univar USA Inc. | 1 Nov 2021 | Human Drugs | View 483 → |
Sites inspected
Silgan Unicep Packaging, LLC.Sandpoint, United States1 insp.
Lonza Bend Inc.Bend, United States1 insp.
Lonza Bend Inc.Bend, United States1 insp.
Omya Inc.Superior, United States1 insp.
Univar USA Inc.Kent, United States1 insp.
Co-investigators
Investigators who share inspections with this person.
Crystal Monroy2 shared
Hung H Do1 shared
Christopher R Czajka1 shared
Kenneth O Gee1 shared
Zachary A Bogorad1 shared
Full investigator report
Get the verbatim findings behind Nathaniel B Phillips Sylvain's 17 observations
Source 483 PDFs, verbatim observations, and how each site responded, so your team knows what they cite before they arrive.
- New inspections and Form 483s, mapped to the CFR citation
- Warning letter outcomes, and the citation patterns they repeat
- Their co-investigators, so no surprises about who shows up on site